Medtronic posted weaker sales in its core pacemaker business in the October quarter, hurt by competition in the market for implanted cardiac defibrillators.
from WSJ.com: US Business http://ift.tt/1vlVheo
via IFTTT
from WSJ.com: US Business http://ift.tt/1vlVheo
via IFTTT
No comments:
Post a Comment